SWHR submitted comments to the FDA in response to draft guidance on considerations for pregnancy safety and lactation studies.
SWHR sent comments to the Food and Drug Administration (FDA) regarding the agency’s new draft guidance on pre- or post-market […]
SWHR provided comments to the Food and Drug Administration (FDA) on its recently released draft guidance pertaining pregnancy safety study […]
SWHR CEO Dr. Amy M. Miller joined an impressive panel of women in the biopharmaceutical industry on Capitol Hill to […]
While great strides have been made in women’s health, there is still much work to be done. It is time […]
The Society for Women’s Health Research commends the Task Force on Research Specific to Pregnant Women and Lactating Women for its comprehensive, evidence-based report with pragmatic recommendations for addressing critical knowledge gaps on safe and effective medication for pregnant and lactating women.
Most of what we know about human health and disease is based on research on men. This is because, until the 1990s, women of reproductive age were actively excluded from most clinical trials. Thanks to efforts by many organizations, including ours, this is changing.
SWHR submitted comments to the federal Food and Drug Administration (FDA) regarding FDA’s recently issued draft guidance on recommendations for the […]
During National Women’s Health Week, you can help create a healthier future for generations to come. How? By sharing a bit of your time and information with the research community.
SWHR provided input on the National Institutes of Health (NIH) strategic plan for research on women’s health to stimulate new […]